LEDA’s official meeting agenda does not list the companies by name. However, this week the Lubbock City Council will be asked to approve an economic incentive between LEDA and Lubbock-based Kiromic LLC.
LEDA is asking permission to provide Kiromic a $60,000 grant to offset the cost of laboratory space.
Public records associated with the City Council’s agenda say Kiromic “is a company consisting of a group of oncologists from the Texas Tech University Health Sciences Center that have [sic] developed a diagnostic kit for early stage cancer detection.”
Those same records say clinical studies have been approved, and “Kiromic will be creating 13 jobs in this phase of their business.”
Not only does the company have an early detection kit, but it also has a method of using cancer’s own proteins against it. In simple terms, a cancer patient’s immune system is reprogrammed to more-effectively attack the cancer.
The title of Kiromic’s website is “The Key To Cancer's Cure.”